Hormonal homeostasis in a group of 216 aging Czech males and correlation with responses to a questionnaire of the University of St Louis

Aging Male

Volumn 9, Issue 2, 2006, Pages 103-110

  Hanus M ^a,c   Matouskova M ^a   Starka L ^b   Hill, M ^b  

^a Urocentrum   (Czech Republic)

^b INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

^c Urocentrum Prague ^*  (Czech Republic)

Author keywords

Aging; Androgens; Andropause; Dehydroepiandrosterone; PADAM; St Louis questionnaire

Indexed keywords

7ALPHA HYDROXYPRASTERONE; 7BETA HYDROXYPRASTERONE; ANDROGEN; ANDROSTANOLONE; ANDROSTENEDIONE; EPITESTOSTERONE; FOLLITROPIN; LUTEINIZING HORMONE; PRASTERONE; PRASTERONE SULFATE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; UNCLASSIFIED DRUG;

ADULT; AGED; AGING; ANDROGEN DEFICIENCY; ANDROGEN METABOLISM; ARTICLE; CORRELATION COEFFICIENT; CZECH REPUBLIC; HOMEOSTASIS; HORMONE BLOOD LEVEL; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PARTIAL ANDROGEN DEFICIENCY IN THE AGING MALE SYNDROME; PRIORITY JOURNAL; QUESTIONNAIRE; SYMPTOMATOLOGY; UNIVERSITY OF SAINT LOUIS QUESTIONNAIRE;

AGED; AGED, 80 AND OVER; CZECH REPUBLIC; HOMEOSTASIS; HORMONES; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES;

EID: 33747605359     PISSN: 13685538     EISSN: 14730790     Source Type: Journal    
DOI: 10.1080/13685530600624150     Document Type: Article

References (32)

1. WHO. Epidemiology and Prevention of Cardiovascular Disease in Elderly People. WHO Technical Reports. Geneva 1995.
2. Gooren LJG. Endocrine aspects of ageing in the male. Mol Cel Endrocrinol 1998;145:153-159.
3. Morales A, Heaton JP, Carson CC 3rd. Andropause: a misnomer for a true clinical entity. J Urol 2000;163:705-712.
4. Morley JE, Charloton E, Patrick P, et al. Validation of a screening questionnaire for androgen deficiency in ageing males. Metabolism 2000;49:1239-1242.
5. Bílek R, Hampl R, Putz Z, Stárka L. Radioimmunoassay of epitestosterone. Methodology, thermodynamic aspects and applications. J Steroid Biochem 1987;28:723-729.
6. Lapčík O, Hampl R, Hill M, Bičíková M, Stárka L. Immunoassay of 7-hydroxysteroids: 1. Radioimmunoassay of 7β-hydroxydehydroepiandrosterone. J Steroid Biochem Mol Biol 1998;67:439-445.
7. Lapčík O, Hampl R, Hill M, Stárka L. Immunoassay of 7-hydroxysteroids: 2. Radio-immunoassay of 7α- hydroxydehydroepiandrosterone. J Steroid Biochem Mol Biol 1999;71:231-237.
8. Vermeulen A. Androgens in the ageing male. J Clin Endocrinol Metab 1991;73:221-224.
9. Morley JE. Testosterone v: Morley JE, van den Berg L, editors. Endocrinol of Ageing. Human Press, Totowa NJ 2000:127-149.
10. Morley JE. Androgens and ageing. Maturitas 2001;38:61-73.
11. Lund BC, Bever Stille KA, Perry PJ. Testosterone and andropause: the feasibility of testosterone replacement therapy in elderly men. Pharmacotherapy 1999;19:951-956.
12. Barrett-Connor E, von Muhlen DG, Kritz-Silverstein D. Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study. J Clin Endocrinol Metab 1999;84:573-577.
13. Jedrzejuk D, Medras M, Milewicz A, Demisse M. Dehydroepiandrosterone replacement in healthy men with age-related decline of DHEA-S: effects on fat distribution, insulin sensitivity and lipid metabolism. Aging Male 2003;56:151-156.
14. Wolf OT, Naumann E, Hellhammer DH, et al. Effects of dehydroepiandrosterone replacement in elderly men on event-related potentials, memory, and well-being. J Gerontol A Biol Sci Med Sci 1998;53A:M385-390.
15. Flynn MA, Weawer-Osterholtz D, Sharpe-Timms KL, et al. Dehydroepiandrosterone replacement in ageing humans. J Clin Endocr Metab 1999;84:1527-1533.
16. Casson PR, Carson SA, Buster JE. Replacement dehydroepiandrosterone in the elderly. Rationale and prospects for the future. Endocrinologist 1998;8:187-194.
17. Herrington DM. DHEA: A biologic conundrum. J Lab Clin Med 1998;131:292-294.
18. Gordon CM, Glowacki J, LeBoff MS. DHEA and the skeleton (through the ages). Endocrine 1999;11:1-11.
19. van Vollenhoven RF. Dehydroepiandrosterone in systemic lupus erythematosus. Rheum Dis Clin North Am 2000;26:349-362.
20. Rabkin JG, Ferrando SJ, Wagner GJ, et al. DHEA treatment for HIV patients: effects on mood, androgenic and anabolic parameters. Psychoneuroendocrinol 2000;25:53-68.
21. Reiter WJ, Schatzl G, Mark I, et al. Dehydroepiandrosterone in the treatment of erectile dysfunction in patents with different organic etiologies. Urol Res 2001;29:278-281.
22. Oberbeck R, Dahlweid M, Koch R, et al. Dehydroepiandrosterone decreases mortality rate and improves cellular immune function during polymicrobial sepsis. Crit Care Med 2001;29:380-384.
23. Morfin R, Lafaye P, Cotillon AC, et al. 7α- Hydroxydehydroepiandrosterone and immune response. Ann N Y Acad Sci 2000;917:971-982.
24. Stárka L. Epitestosterone: a review. J Steroid Biochem Mol Biol 2003;87:27-34.
25. Morales A, Lunenfeld B. Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 2002;5:74-86.
26. Nicopoulou, SCN, Adamopoulos DAA. Aging male 2001;4:8-13.
27. Vermeulen A. Andropause. Maturitas 2000;34:5-15.
28. rd. The endocrinology of ageing. Clin Chem 1999;45:1369-1372.
29. Vermeulen A. Androgen replacement therapy in the ageing male - a critical evaluation. J Clin Endocrinol Metab 2001;86:2380-2390.
30. Hermann M, Berger P. Hormonal changes in ageing men: a therapeutic indication? Exper Gerontol 2001;36:1075-1082.
31. Morales A. Andropause, androgen therapy and prostate safety. Aging Male 1999;2:81-86.
32. Negro-Vilar A. Selective androgen receptor modulator (SARMs): A novel approach to androgen therapy for the new millennium. J Clin Endocrinol Metab 1999;84:3459-3462.